Form 4: Pulmonx Corp Executive Rose Geoffrey Beran Sells 1,184 Shares
SEC Form 4
Chief Commercial Officer of Pulmonx Corp, Rose Geoffrey Beran, sold 1,184 shares of common stock at $7.49 per share on April 22, 2024, according to a Form 4 filing.
Summary
- Rose Geoffrey Beran, Chief Commercial Officer of Pulmonx Corp, reported a transaction on April 22, 2024.
- Beran sold 1,184 shares of Pulmonx Corp common stock at a price of $7.49 per share.
- Following the transaction, Beran directly owns 306,684 shares of Pulmonx Corp.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 24, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale by an executive under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Insider sales are a common occurrence and are often scrutinized by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, sales under 10b5-1 plans are pre-arranged and may not reflect current sentiment.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 05/24/2023 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| 04/22/2024 | Date of the stock sale transaction |
| 04/24/2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.